Small tumor size and node-negative HER2-positive breast cancer: a step forward for a better treatment?

MOLINO, Annamaria
2010

Breast Neoplasms; mortality/pathology/therapy, Chemotherapy; Adjuvant, Combined Modality Therapy, Disease-Free Survival, Female, Humans, Lymph Nodes; pathology, Mastectomy; Segmental; methods, Neoplasm Invasiveness; pathology, Neoplasm Staging, Prognosis, Radiotherapy; Adjuvant, Receptor; erbB-2; analysis, Risk Assessment, Survival Analysis, Time Factors, Tumor Burden
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/388329
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 4
social impact